Biopharma group UCB’s newly appointed Chief Executive Officer, Jean-Christophe Tellier, is already making waves in the industry, having been selected to join the Ministerial Industry Strategy Group (MISG).more »

Features

Blueprint Medicines has announced a strategic collaboration with Alexion to discover, develop and commercialise novel drug candidates for an undisclosed activated kinase target, which is the cause of a rare genetic disease.more »